Medicinova Inc. buy melinda
Start price
15.10.17
/
50%
€6.09
Target price
26.10.17
€6.31
Performance (%)
7.41%
End price
26.10.17
€6.54
Summary
This prediction ended on 26.10.17 with a price of €6.54. With a performance of 7.41%, the BUY prediction by melinda for Medicinova Inc. closed with a slight gain. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Medicinova Inc. | - | - | - | - |
| iShares Core DAX® | 2.687% | -4.620% | 11.789% | 9.959% |
| iShares Nasdaq 100 | 5.569% | -7.315% | 24.297% | 36.179% |
| iShares Nikkei 225® | 3.756% | -7.813% | 10.017% | 3.466% |
| iShares S&P 500 | 3.959% | -3.697% | 21.637% | 35.681% |
Comments by melinda for this prediction
In the thread Medicinova Inc. diskutieren
Progredienter Multipler Sklerose (progressive MS)
Die erste Zeile der Daten aus dem Phase - 2b wird 28. Oktober präsentiert wird 2017 auf der gemeinsamen Sitzung ECTRIMS - ACTRIMS.